These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28431800)

  • 1. Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.
    Li J; Yoshikawa A; Brennan MD; Ramsey TL; Meltzer HY
    Schizophr Res; 2018 Feb; 192():194-204. PubMed ID: 28431800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the genetic risk factors for treatment response to lurasidone by genome-wide association study: A meta-analysis of samples from three independent clinical trials.
    Li J; Loebel A; Meltzer HY
    Schizophr Res; 2018 Sep; 199():203-213. PubMed ID: 29730043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional HTR1A polymorphism, rs6295, predicts short-term response to lurasidone: confirmation with meta-analysis of other antipsychotic drugs.
    Yoshikawa A; Li J; Meltzer HY
    Pharmacogenomics J; 2020 Apr; 20(2):260-270. PubMed ID: 31636356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
    Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
    Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Lurasidone on symptoms of schizophrenia in five-factor dimensional model: pooled analysis of two short-term, randomized, double-blind, placebo-controlled studies in patients from Russia and Ukraine].
    Mosolov SN; Malyutin AV; Pikalov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12):29-37. PubMed ID: 31994511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of lurasidone across five symptom dimensions of schizophrenia: pooled analysis of short-term, placebo-controlled studies.
    Loebel A; Cucchiaro J; Silva R; Mao Y; Xu J; Pikalov A; Marder SR
    Eur Psychiatry; 2015 Jan; 30(1):26-31. PubMed ID: 25280429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia.
    Tandon R; Cucchiaro J; Phillips D; Hernandez D; Mao Y; Pikalov A; Loebel A
    J Psychopharmacol; 2016 Jan; 30(1):69-77. PubMed ID: 26645209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lurasidone in the treatment of schizophrenia: Results of a double-blind, placebo-controlled trial in Asian patients.
    Higuchi T; Ishigooka J; Iyo M; Yeh CB; Ebenezer EG; Liang KY; Lee JS; Lee SY; Lin SK; Yoon BH; Nakamura M; Hagi K; Sato T
    Asia Pac Psychiatry; 2019 Jun; 11(2):e12352. PubMed ID: 30950208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.
    Loebel A; Cucchiaro J; Sarma K; Xu L; Hsu C; Kalali AH; Pikalov A; Potkin SG
    Schizophr Res; 2013 Apr; 145(1-3):101-9. PubMed ID: 23415311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.
    Meltzer HY; Cucchiaro J; Silva R; Ogasa M; Phillips D; Xu J; Kalali AH; Schweizer E; Pikalov A; Loebel A
    Am J Psychiatry; 2011 Sep; 168(9):957-67. PubMed ID: 21676992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trial.
    Higuchi T; Iyo M; Kwon JS; Chou YH; Chen HK; Chen JY; Chen TT; Huang SY; Lee JS; Saeki Y; Tanaka H; Wang TS; Wu BJ; Katoh T; Ishigouoka J
    Asia Pac Psychiatry; 2019 Sep; 11(3):e12354. PubMed ID: 30912222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study.
    Goldman R; Loebel A; Cucchiaro J; Deng L; Findling RL
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):516-525. PubMed ID: 28475373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.
    ; Amare AT; Schubert KO; Hou L; Clark SR; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Brichant-Petitjean C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski PM; Dalkner N; Dayer A; Del Zompo M; DePaulo JR; Étain B; Falkai P; Forstner AJ; Frisen L; Frye MA; Fullerton JM; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Hofmann A; Jamain S; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Kliwicki S; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Ösby U; Pfennig A; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Volkert J; Witt S; Wright A; Zandi PP; Mitchell PB; Bauer M; Alda M; Rietschel M; McMahon FJ; Schulze TG; Baune BT
    JAMA Psychiatry; 2018 Jan; 75(1):65-74. PubMed ID: 29121268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.
    Nasrallah HA; Silva R; Phillips D; Cucchiaro J; Hsu J; Xu J; Loebel A
    J Psychiatr Res; 2013 May; 47(5):670-7. PubMed ID: 23421963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation.
    Loebel A; Citrome L; Correll CU; Xu J; Cucchiaro J; Kane JM
    BMC Psychiatry; 2015 Oct; 15():271. PubMed ID: 26521019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
    Citrome L
    Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study.
    Loebel A; Silva R; Goldman R; Watabe K; Cucchiaro J; Citrome L; Kane JM
    J Clin Psychiatry; 2016 Dec; 77(12):1672-1680. PubMed ID: 27454547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia.
    Meltzer HY; Share DB; Jayathilake K; Salomon RM; Lee MA
    J Clin Psychopharmacol; 2020; 40(3):240-249. PubMed ID: 32332459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder.
    Potkin SG; Ogasa M; Cucchiaro J; Loebel A
    Schizophr Res; 2011 Nov; 132(2-3):101-7. PubMed ID: 21889878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta-analysis of phase 3 trials in Japan.
    Kishi T; Nosaka T; Sakuma K; Okuya M; Iwata N
    Neuropsychopharmacol Rep; 2020 Sep; 40(3):314-322. PubMed ID: 32767739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.